Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs to treat their condition: Lilly says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken diabetes drugs in three just-concluded Phase III studies.
Recently while I was out shopping with my sister, I tested my blood sugar and found that I had a high reading of 217. Because I had just downed a non-fat pumpkin spice latte and still had active insulin in my bloodstream, I skipped correcting it with an insulin shot and went on trying on clothing and chatting with my sister. When I got to my car afterward, I realized that I felt a little like I was drunk, so I figured that I'd better test my blood sugar again. It was 58.
When people with diabetes are successful and happy, their situation is often viewed as having been achieved despite the obstacle of diabetes. I am advocating for a shift in that perception. What if instead of seeing all the good in our lives as existing despite our disease, we begin to see everything that we are—the challenges and the achievements—as a direct product of all that we are made up of, diabetes included?
A British study of type 2 men reports that although testosterone therapy had a beneficial effect on blood glucose levels and other metabolic indicators for non-depressed men, those suffering from depression experienced no benefit. In fact, reports Geoffrey Hackett, MD, at Good Hope Hospital in Sutton Coldfield, depressed men actually experienced a worsening of symptoms.
Recently, while scrolling through discussions posted on an online diabetes forum, I came across one from a man in his thirties who wrote about how paramedics had found his twin brother face down in a sauna, in an insulin shock coma. How did he end up in such a state? The appalling answer is, he didn't have enough glucose strips to test before he got into the hot tub. A few weeks before the sauna incident, his insurance company had limited his glucose strips to just four per day.
The new Accu-Chek Nano was approved for diabetes patients in January 2012, and distribution of the product began in April. Jennifer Aspy, the director of product marketing and operations, sat down with me at the American Association of Diabetes Educators to talk about the merits of this new medical device.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.